Weight gain and family history of prostate or breast cancers as risk factors for prostate cancer: Results of a case-control study in Japan

Asian Pacific Journal of Cancer Prevention

Volumn 12, Issue 3, 2011, Pages 743-747

  Mori, Mitsuru ^a   Masumori, Naoya ^a   Fukuta, Fumimasa ^a   Nagata, Yoshie ^a   Sonoda, Tomoko ^a   Miyanaga, Naoto ^b   Akaza, Hideyuki ^c   Tsukamoto, Taiji ^a  

^a SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b UNIVERSITY OF TSUKUBA   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

Author keywords

Body mass index; Case control study; Family history; Prostate cancer; Weight gain

Indexed keywords

EID: 79958831945     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Andersson S-O, Wolk A, Bergström R, et al. (1996). Energy, nutrient intake and prostate cancer risk: a population-based case-control study in Sweden. Int J Cancer, 68, 716-22
2. Bradbury BD, Wilk JB, Kaye JA (2005). Obesity and the risk of prostate cancer (United States). Cancer Causes Control, 16, 637-41
3. Breslow NE, Day NE (1980). Statistical Methods in Cancer Research. Volume 1 - The Analysis of Case-control Studies. IARC Scientific Publications No. 32, IARC, Lyon, pp. 248-80
4. Carter BS, Beaty TH, Steinberg GD, Childs B, Walsh PC (1992). Mendelian inheritance of familial prostate cancer. Proc Natl Acad Sci USA, 89, 3367-71
5. Cerhan JR, Parker AS, et al (1999). Family history and prostate cancer risk in a population-based cohort of Iowa men. Cancer Epidemiol Biomarkers Prev, 8, 53-60
6. Dal Maso L, Zucchetto A, La Vecchia C, et al (2004). Prostate cancer and body size at different ages: an Italian multicentre case-control study. Br J Cancer, 90, 2176-80
7. Eldon BJ, Jonsson E, Tomasson J, Tryggvadottir L, Tulinius H (2003). Familial risk of prostate cancer in Iceland. BJU Int, 92, 915-9
8. Engeland A, Tretli S, Bjørge T (2003). Height, body mass index, and prostate cancer: a follow-up of 950,000 Norwegian men. Br J Cancer, 89, 1237-42
9. Fujimoto K, Tanaka M, Hirao Y, et al (2008). Age-stratified serum levels of isoflavones and proportion of equol producers in Japanese and Korean healthy men. Prostate Cancer Prostatic Dis,11, 252-7
10. Ghadirian P, Cadott M, Lacroix A, Perret C (1991). Family aggregation of cancer of the prostate in Quebec: the tip of the iceberg. Prostate, 19, 43-52
11. Ghadirian P, Howe GR, Hislop TG, Maisonneuve P (1997). Family history of prostate cancer: a multi-center case-control study in Canada. Int J Cancer, 70, 679-81
12. Giovannucci E, Rimm EB, Liu Y, et al (2003). Body mass index and risk of prostate cancer in U.S health professionals. J Natl Cancer Inst, 95, 1240-4
13. Gong Z, Neuhouse ML, Goodman PJ, et al (2006). Obesity, diabetes, and risk of prostate cancer: Results from the Prostate Cancer Prevention Trial. Cancer Epidemiol Biomarkers Prev, 15, 1977-83
14. Grönberg H, Damber L, Damber JE (1996a). Total food consumption and body mass index in relation to prostate cancer risk: a case-control study in Sweden with prospectively collected exposure data. J Urol, 155, 969-74
15. Grönberg H, Damber L, Damber JE (1996b). Familial prostate cancer in Sweden. Cancer, 77, 138-43
16. Grönberg H, Bergh A, Damber J-E, Emanuelsson M (2000). Cancer risk in families with hereditary prostate carcinoma. A possible link between prostate, breast, and gastric carcinoma. Cancer, 89, 1315-21
17. Hayes RB (2001). Gene-environment interactions in prostate cancer. Epidemiol Rev, 23, 163-7
18. Health and Welfare Statistics Association. Trend of National Health (2009). J Health Welfare Stat, 56 (Suppl), 84 (Japanese text)
19. Hsieh LJ, Carter B, Landis PK, et al (2003). Association of energy intake with prostate cancer in a long-term aging study: Baltimore longitudinal study of aging (United States). Urology, 61, 297-301
20. Karakiewicz PI, Foulkes W, Tanguay S, Elhilai MM, Aprikian AG (2003). Familial prostate and breast cancer in men treated with prostatectomy for prostate cancer. J Urol, 169, 240-4
21. Kristal AR, Cohen JH, Qu P, Stanford JL (2002). Association of energy, fat, calcium, and vitamin D with prostate cancer risk. Cancer Epidemiol Biomarkers Prev, 11, 719-25
22. Lesko SM, Rosenberg L, Shapiro S (1996). Family history and prostate cancer risk. Am J Epidemiol, 144, 1041-7
23. Littman AJ, White E, Kristal AR (2007). Anthropometrics and prostate cancer. Am J Epidemiol, 165, 1271-9
24. MacInnis RJ, English DR, Gertig DM, Hopper JL, Giles GG (2003). Body size and composition and prostate cancer risk. Cancer Epidemiol Biomarkers Prev, 12, 1417-21
25. Matsuda T, Marugame T, Kamo K, et al (2009). Cancer incidence and incidence rates in Japan in 2003: Based on data from 13 population-based cancer registries in the monitoring of cancer incidence in Japan (MCIJ) project. Jpn J Clin Oncol, 39, 850-8
26. Mori M, Masumori N, Fukuta F, et al (2009). Traditional Japanese diet and prostate cancer. Mol Nutr Food Res, 53, 191-200
27. Nagata, Y, Sonoda, T, Mori, M, et al (2007). Dietary isoflavones may protect against prostate cancer in Japanese men. J Nutr, 137, 1974-9
28. Negri E, Pelucchi C, Talamini R, et al (2005). Family history of cancer and the risk of prostate cancer. Int J Cancer, 114, 648-52
29. Parkin, DM, Whelan, SL, Ferlay, WJ, Teppo, L, Thomas, DB (2002). Cancer Incidence in Five Continents. Vol 8. IARC Scientific Publications No. 155, Oxford Univ Press, Oxford, pp. 633-5
30. Plats EA, Giovannucci E (2002). Prostate Cancer. Eds Schottenfeld D, Fraumeni JF Cancer Epidemiology and Prevention. Third Edition. Oxford Univ Press, Oxford, 1128-50
31. Porter MP, Stanford JL (2005). Obesity and the risk of prostate cancer. Prostate, 62, 316-21
32. Rodriguez C, Patel AV, Calle EE, et al (2001). Body mass index, height, and prostate cancer mortality in two large cohorts of adult men in the United States. Cancer Epidemiol Biomarkers Prev, 10, 345-53
33. Rodriguez C, Freedland SJ, Deka A, et al (2007). Body mass index, weight change, and risk of prostate cancer in the Cancer Prevention Study II Nutrition Cohort. Cancer Epidemiol Biomarkers Prev, 16, 63-9
34. SAS Institute Inc (1995). Logistic Regression Examples Using the SAS System. Version 6, First Edition, Cary, 119-24
35. Spangler E, Zeigler-Johnson CM, Malkowicz SB, Wein AJ, Rebbeck TR (2005). Association of prostate cancer family history with histopathological and clinical characteristics of prostate tumors. Int J Cancer, 113, 471-4
36. Stanford JL (2001). Familial prostate cancer. Epidemiol Rev, 23, 19-23
37. Stevens J, Keil JE, Wail R, Gazes PC (1990). Accuracy of current, 4-year, and 28-year self-reported body weight in an elderly population. Am J Epidemiol, 132, 1156-63
38. The Breast Cancer Linkage Consortium (1999). Cancer risks in BRCA2 mutation carriers. J Natl Cancer Inst, 91, 1310-6
39. Whittemore AS, Wu AH, Kolonel LN, et al (1995). Family history and prostate cancer risk in black, white, and Asian men in the United States and Canada. Am J Epidemiol, 141, 732-40
40. Wright ME, Chang S-C, Schatzkin A, et al (2007). Prospective study of adiposity and weight change in relation to prostate cancer incidence and mortality. Cancer, 109, 675-84.